![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2020
Huhn, Maximilian; Leucht, Claudia; Rothe, Philipp; Dold, Markus; Heres, Stephan; Bornschein, Susanne; Schneider-Axmann, Thomas; Hasan, Alkomiet und Leucht, Stefan
(2020):
Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 271, Nr. 2: S. 293-302
Hasan, Alkomiet; Roeh, Astrid; Leucht, Stefan; Langguth, Berthold; Hansbauer, Maximilian; Oviedo-Salcedo, Tatiana; Kirchner, Sophie K.; Papazova, Irina; Loehrs, Lisa; Wagner, Elias; Maurus, Isabel; Strube, Wolfgang; Rossner, Moritz J.; Wehr, Michael C.; Bauer, Ingrid; Heres, Stephan; Leucht, Claudia; Kreuzer, Peter M.; Zimmermann, Stephanie; Schneider-Axmann, Thomas; Goerlitz, Thomas; Karch, Susanne; Egert-Schwender, Silvia; Schossow, Beate; Rothe, Philipp und Falkai, Peter
(2020):
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial.
In: Contemporary Clinical Trials Communications, Bd. 17, 100537
2018
Krause, Marc; Huhn, Maximilian; Schneider-Thoma, Johannes; Rothe, Philipp; Smith, Robert C. und Leucht, Stefan
(2018):
Antipsychotic drugs for elderly patients with schizophrenia: A systematic review and meta-analysis.
In: European Neuropsychopharmacology, Bd. 28, Nr. 12: S. 1360-1370